Detalhe da pesquisa
1.
Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease.
Blood
; 119(10): 2228-33, 2012 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-22223822
2.
Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study.
Blood
; 113(17): 3947-52, 2009 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-18987358
3.
Association of Occupational Pesticide Exposure With Immunochemotherapy Response and Survival Among Patients With Diffuse Large B-Cell Lymphoma.
JAMA Netw Open
; 2(4): e192093, 2019 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31002318
4.
Risk of second cancer in nongastric marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue: a population-based study from northern Italy.
Clin Cancer Res
; 13(1): 182-6, 2007 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17200353
5.
An insidious presentation of splenic marginal zone lymphoma.
Clin Lymphoma Myeloma
; 7(6): 432-3, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17621411
6.
Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment.
Leuk Res
; 30(3): 277-82, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16112730
7.
Role of the molecular staging and response in the management of follicular lymphoma patients.
Leuk Lymphoma
; 47(6): 1018-22, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16840191
8.
Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma.
Clin Lymphoma
; 4(4): 250-2, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15072617
9.
Iatrogenic acquired factor V inhibitors: A case report and review of the French pharmacovigilance database.
Thromb Res
; 157: 154-156, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28755628
10.
Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease.
Br J Haematol
; 136(2): 301-4, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17233821
11.
Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders.
Blood
; 107(9): 3676-82, 2006 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16373657
12.
Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination.
Oncologist
; 11(3): 285-91, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16549813
13.
Splenic marginal zone lymphoma: a prognostic model for clinical use.
Blood
; 107(12): 4643-9, 2006 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16493005
14.
Immunochemotherapy with rituximab, vincristine and 5-day cyclophosphamide for heavily pretreated follicular lymphoma.
Oncology
; 68(2-3): 146-53, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16006752
15.
Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
Cancer
; 100(1): 107-15, 2004 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14692030
16.
A paraumbilical lymphomatous mass.
Eur J Haematol
; 77(2): 180, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16856915